Fibronectin autoantibodies

Autoantibodies

Volumn , Issue , 2007, Pages 325-329

  Feist, Eugen ^a   Hiepe, Falk ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053251376     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452763-9/50047-0     Document Type: Chapter

References (14)

1. Atta MS, Lim KL, Ala'deen DA, Powell RJ, Todd I Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus. Ann Rheum Dis 1995, 54(2):117-124. Feb.
2. Mao Y Schwarzbauer JE. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 2005, 24(6):389-399. Sep.
3. Peters JH, Carsons S, Yoshida M, Ko F, McDougall S, Loredo GA, Hahn TJ Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 2003, 5(6):R329-R339.
4. Sen M, Reifert J, Lauterbach K, Wolf V, Rubin JS, Corr M, Carson DA Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum 2002, 46(11):2867-2877. Nov.
5. Voskuyl AE, Hazes JM, Zwinderman AH, Paleolog EM, van der Meer FJ, Daha MR, Breedveld FC Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis 2003, 62(5):407-413. May.
6. Atta MS, Powell RJ, Hopkinson ND, Todd I Human anti-fibronectin antibodies in systemic lupus erythematosus: occurrence and antigenic specificity. Clin Exp Immunol 1994, 96(1):20-25. Apr.
7. Polgar A, Falus A, Koo E, Ujfalussy I, Sesztak M, Szuts I, Konrad K, Hodinka L, Bene E, Meszaros G, Ortutay Z, Farkas E, Paksy A, Buzas EI Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford) 2003, 42(4):522-527. Apr.
8. Atta MS, Powell RJ, Todd I The influence of anti-fibronectin antibodies on interactions involving extracellular matrix components and cells: A possible pathogenic mechanism. Clin Exp Immunol 1994, 96(1):26-30. Apr.
9. Rostagno AA, Gallo G, Gold LI Binding of polymeric IgG to fibronectin in extracellular matrices: An in vitro paradigm for immune-complex deposition. Mol Immunol 2002, 38(15):1101-1111. Jun.
10. Maehnss K, Kobarg J, Schmitt WH, Hansen HP, Lange H, Csernok E, Gross WL, Lemke H Vitronectin-and fibronectin-containing immune complexes in primary systemic vasculitis. J Autoimmun 2002, 18(3):239-250. May.
11. Fornasieri A, Armelloni S, Bernasconi P, Li M, de Septis CP, Sinico RA, D'Amico G High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: A mechanism for induction of in situ immune complex glomerulonephritis?. Am J Kidney Dis 1996, 27(4):476-483. Apr.
12. Cuchacovich M, Gatica H, Grigg DM, Pizzo SV, Gonzalez-Gronow M Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis. J Rheumatol 1996, 23(1):44-51. Jan.
13. Cortes-Hernandez J, Ordi-Ros J, Labrador M, Bujan S, Balada E, Segarra A, Vilardell-Tarres M Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med 2004, 116(3):165-173. Feb 1.
14. Mavropoulos JC, Cuchacovich M, Llanos C, et al. Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis. J Rheumatol 2005, 32(11):2116-2124. Nov.